24 years treating AML
Dr. Hildebrandt's research focus is on patients with cancers of the blood and lymph system, patients before and after blood or marrow stem cell transplantation and on patients suffering from acute and chronic graft versus host disease.
Subscribe to the weekly "HealthTree Community for AML Newsletter" for AML news, life with AML stories, AML clinical trials, AML 101 articles and events with AML experts.
Terms of Use and Privacy Policy Newsroom About Donations Find an AML Specialist Newsletter Learn Connect
Copyright © 2022 HealthTree Foundation. All Rights Reserved.
The HealthTree Foundation / HealthTree for AML is a qualified 501(c)(3) tax-exempt organization. Tax ID 45-5354811